Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult

Molecular Pharmacology

Volumn 55, Issue 6, 1999, Pages 1044-1048

  Koch, H P ^a   Chamberlin, A R ^b   Bridges, Richard J ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; POTASSIUM CYANIDE; PYRROLIDINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; COMPETITIVE INHIBITION; CYTOTOXICITY; GABAERGIC SYSTEM; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE; SYNAPTOSOME;

EID: 0032976901     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.6.1044     Document Type: Article

References (39)

1. Amin N. and Pearce B (1997) Glutamate toxicity in neuron-enriched and neuron-astrocyte co-cultures: Effect of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate. Neurochem Int 30:271-276.
2. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP and Amara SG (1994) Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14:5559-5569.
3. Benveniste H, Drejer J, Schousboe A and Diemer NH (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374.
4. Booth RFG and Clark JB (1978) A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain. Biochem J 176:365-370.
5. Bridges RJ, Kavanaugh MP, Zerangue N, Koch H, Esslinger S, Humphrey J, Amara SG and Chamberlin AR (1996) Conformationally constrained inhibitors of the human glutamate transporters: Differentiation of substrates and non-transportable blockers. Soc Neurosci Abs 22:619.5
6. Bridges RJ, Lovering FE, Koch H, Cotman CW and Chamberlin AR (1994) A conformationally constrained competitive inhibitor of the sodium-dependent glutamate transporter in forebrain synaptosomes: L-anti-endo-3,4-methanopyrrolidine dicarboxylate. Neurosci Lett 174:193-197.
7. Bridges RJ, Stanley MS, Anderson MW, Cotman CW and Chamberlin AR (1991) Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 34:717-725.
8. Choi DW (1994) Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 100:47-51.
9. Cotman CW, Kahle JS, Miller SE, Ulas J and Bridges RJ (1995) Excitatory amino acid neurotransmission, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 75-85, Raven Press, New York.
10. Gegelashvili G and Schousboe A (1998) Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res Bull 45:233-238.
11. Gemba T, Oshima T and Ninomiya M (1994) Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 63:789-795.
12. Griffiths R, Dunlop J, Gorman A, Senior J and Grieve A (1994) L-trans-pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters. Biochem Pharmacol 47:267-274.
13. Hauptman M, Nelson D, Wilson DF and Erecinska M (1984) Neurotransmitter amino acids in the CNS. II. Some changes in amino acid levels in rat brain synaptosomes during and after in vitro anoxia and simulated ischemia. Brain Res 304:23-35.
14. Henn FA, Anderson DJ and Rustad DG (1976) Glial contamination of synaptosomal fractions. Brain Res 101:341-344.
15. Humphrey JM, Bridges RJ, Hart JA and Chamberlin AR (1994) 2,3-Pyrrolidinedi-carboxylates as neurotransmitter conformer mimics: Enantioselective synthesis via chelation-controlled enolate alkylation. J Org Chem 59:2467-2472.
16. Kanai Y and Hediger MA (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360:467-471.
17. Kanner BI and Marva E (1982) Efflux of L-glutamate by synaptic plasma membrane vesicles isolated from rat brain. Biochemistry 21:3143-3147.
18. 2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemia and anoxia. Neuroscience 27:175-182.
19. Kimelberg HK, Goderie SK, Pang S and Waniewski RA (1990) Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci 10:1583-1591.
20. Longuemare MC and Swanson RA (1995) Excitatory amino acid release from astrocytes during energy failure by reversal of sodium-dependent uptake. J Neurosci Res 40:379-386.
21. Madl JE and Burgesser K (1993) Adenosine triphosphate depletion reverses sodium-dependent, neuronal uptake of glutamate in rat hippocampal slices. J Neurosci 13:4429-4444.
22. Obrenovitch TP, Urenjak J and Zilkha E (1997) Effects of increased extracellular glutamate levels on the local field potential in the brain of anaesthetized rats. Br J Pharmacol 122:372-378.
23. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E and Kanner BI (1992) Cloning and expression of a rat brain L-glutamate transporter. Nature 360:464-467.
24. Reiner PB, Laycock AG and Doll CJ (1990) A pharmacological model of ischemia in the hippocampal slice. Neurosci Lett 119:175-178.
25. Robinson MB, Djali S and Buchhalter JR (1993) Inhibition of glutamate uptake with L-trans-pyrrolidine-2,4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures. J Neurochem 61:2099-2103.
26. Roettger V and Lipton P (1996) Mechanism of glutamate release from rat hippocampal slices during in vitro ischemia. Neuroscience 75:677-685.
27. Rothman SM and Olney JW (1995) Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurol Sci 18:57-58.
28. Rothstein JD, Jin L, Dykes-Hoberg M and Kuncl RW (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90:6591-6595.
29. 2+-independent release of glutamate during anoxia in isolated nerve terminals (synaptosomes). J Neurochem 50:1322-1324.
30. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
31. +-dependent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 88:10955-10959.
32. Szatkowski M and Attwell D (1994) Triggering and execution of neuronal death in brain ischemia: Two phases of glutamate release by different mechanisms. Trends Neurol Sci 17:359-365.
33. Tabb JS and Ueda T (1991) Phylogenetic studies on the synaptic vesicle glutamate transport system. J Neurosci 11:1822-1828.
34. Takahashi M, Billups B, Rossi D, Sarantis M, Hamann M and Attwell D (1997) The role of glutamate transporters in glutamate homeostasis in the brain. J Exp Biol 200:401-409.
35. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M and Wada K (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699-1702.
36. Vandenberg RJ (1998) Molecular pharmacology and physiology of glutamate transporters in the central nervous system. Clin Exp Pharmacol Physiol 25:393-400.
37. Volterra A, Bezzi P, Rizzini BL, Trotti D, Ullensvang K, Danbolt NC and Racagni G (1996) The competitive transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition. Eur J Neurosci 8:2019-2028.
38. Wilson DF and Pastuszko A (1986) Transport of cysteate by synaptosomes isolated from rat brain: evidence that it utilizes the same transporter as aspartate, glutamate, and cysteine sulfinate. J Neurochem 47:1091-1097.
39. Zeevalk GD and Nicklas WJ (1991) Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J Pharmacol Exp Ther 257:870-878.